Hepatitis B in Moroccan-Dutch: a qualitative study into determinants of screening participation.

Autor:	Hamdiui N; National Coordination Centre for Communicable Disease Control, Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.; Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands., Stein ML; National Coordination Centre for Communicable Disease Control, Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands., van der Veen YJJ; Christian University of Applied Sciences Ede, Ede, The Netherlands., van den Muijsenbergh METC; Program Prevention and Care, Pharos: Dutch Centre of Expertise on Health Disparities, Utrecht, The Netherlands.; Department of Primary and Community Care, Radboud University Medical Center, Nijmegen, The Netherlands., van Steenbergen JE; National Coordination Centre for Communicable Disease Control, Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.; Centre for Infectious Diseases, Leiden University Medical Centre, Leiden, The Netherlands.
Jazyk:	angličtina
Zdroj:	European journal of public health [Eur J Public Health] 2018 Oct 01; Vol. 28 (5), pp. 916-922.
DOI:	10.1093/eurpub/cky003
Abstrakt:	Background: Chronic hepatitis B (HBV) leads to an increased risk for liver cirrhosis and liver cancer. In the Netherlands, chronic HBV prevalence in the general population is 0.20%, but 3.77% in first generation immigrants. Our aim was to identify determinants associated with the intention to participate in HBV testing among first generation Moroccan immigrants, one of the two largest immigrant groups targeted for screening. Methods: Semi-structured interviews were held with first (n = 9) and second generation (n = 10) Moroccan-Dutch immigrants, since second generation immigrants frequently act as their parents' brokers in healthcare. Results: Most participants had little knowledge about hepatitis B, but had a positive attitude towards screening. Facilitators for screening intention were perceived susceptibility to and severity of disease, positive attitude regarding prevention, wishing to know their hepatitis B status and to prevent potential hepatitis B transmission to others. Additional cultural facilitators included fear (of developing cancer), and existing high health care utilization; a religious facilitator was the responsibility for one's own health and that of others. Barriers included lack of awareness and knowledge, practical issues, not having symptoms, negative attitude regarding prevention, fear about the test result and low-risk perception. A cultural barrier was shame and stigma, and a religious barrier was fatalism. Conclusion: We identified important facilitators and barriers, which we found, can be interpreted differently. Specific and accurate information should be provided, accompanied by strategies to address shame and stigma, in which Islamic religious leaders could play a role in bringing information across.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu